According to Biolase 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.0840. At the end of 2024 the company had a P/S ratio of 0.0536.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.0536 | -31.25% |
2023 | 0.0780 | -18.66% |
2022 | 0.0958 | -93.72% |
2021 | 1.53 | -10.82% |
2020 | 1.71 | 272.09% |
2019 | 0.4597 | 1.71% |
2018 | 0.4520 | -51.4% |
2017 | 0.9299 | -49.07% |
2016 | 1.83 | 80.71% |
2015 | 1.01 | -68.5% |
2014 | 3.21 | 81.7% |
2013 | 1.77 | 74.93% |
2012 | 1.01 | -37.34% |
2011 | 1.61 | -0.92% |
2010 | 1.63 | 51.33% |
2009 | 1.07 | 92.15% |
2008 | 0.5590 | -34% |
2007 | 0.8469 | -71.63% |
2006 | 2.98 | -0.58% |
2005 | 3.00 | -25.42% |
2004 | 4.03 | -44.73% |
2003 | 7.28 | 87.73% |
2002 | 3.88 | -38.19% |
2001 | 6.28 |